Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 24:11:102338.
doi: 10.1016/j.mex.2023.102338. eCollection 2023 Dec.

Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model

Affiliations

Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model

Jessica Copeland et al. MethodsX. .

Abstract

The diagnosis and treatment of lung cancer is challenged by complex diagnostic pathways and fragmented care that can lead to disparities for vulnerable patients. Our model involved a multi-institutional, multidisciplinary conference to address the complexity of lung cancer care in vulnerable patient populations. The conference was conducted using a process adapted from the problem-solving method entitled FastTrack, pioneered by General Electric. Conference attendees established critical social determinants of health specific to lung cancer and designed a practical care model to accelerate diagnosis and treatment in this population. The resulting care delivery model, the Lung Cancer Strategist Program (LCSP), was led by a lung cancer trained advanced practice provider (APP) to expedite diagnosis, surgical and oncologic consultation, and treatment of a suspicious lung nodule. We compared the timeliness of care, care efficiency, and oncologic outcomes in 100 LCSP patients and 100 routine referral patients at the same thoracic surgery clinic. Patient triage through our integrated care model transitioned initial referral evaluation to a lung cancer trained APP to coordinate multidisciplinary patient-centered care that was highly individualized and significantly reduced the time to diagnosis and treatment among vulnerable patients at high-risk for treatment delay due to healthcare disparities.•To develop the Lung Cancer Strategist Program care model, we used a three-step (Design, Meeting, and Culmination), team-based, problem-solving process entitled FastTrack.•An advantage of FastTrack is its ability to overcome barriers embedded within hierarchal and institutional social systems, empowering those closest to the relevant issue to propose and enact meaningful change.•Under this framework, we engaged a diverse field of experts to assess systemic barriers in lung cancer care and design an innovative care pathway to improve the timeliness and efficiency of lung cancer care in patients at risk for healthcare disparities.

Keywords: Healthcare disparities; Integrative multidisciplinary care; Lung Cancer Strategist Program (care model developed) based off of FastTrack (method used to develop the care model); Non-small cell lung cancer; Novel healthcare delivery model; Social determinants of health.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig. 1
Integrating barriers (Venn Diagram) and solutions (Outer Circle) to common failure points across the spectrum of lung cancer care.
Fig 2
Fig. 2
Current status of lung cancer care, lung cancer is one of the most complex clinical problems in the healthcare system. Patients can enter through multiple avenues and have multiple providers involved in the diagnosis, treatment, and maintenance of their disease.
Fig 3
Fig. 3
Fishbone diagram outlining key factors that increase healthcare disparities along the spectrum of lung cancer care.
Fig 4
Fig. 4
Overview and workflow of the lung cancer strategist program.
Fig 5
Fig. 5
Patients were deemed high-risk for treatment delay based on vulnerability characteristics that are represented across the LCSP cohort and routine referral cohort.
Fig 6
Fig. 6
Diagnostic and treatment timeline for the LCSP cohort compared to the routine referral cohort.

Similar articles

Cited by

  • Biomarkers: a new frontier in lung cancer detection.
    Pura-Bryant J, Olivera JA, Antonoff MB. Pura-Bryant J, et al. Transl Lung Cancer Res. 2024 Jan 31;13(1):210-212. doi: 10.21037/tlcr-23-801. Epub 2024 Jan 22. Transl Lung Cancer Res. 2024. PMID: 38404994 Free PMC article. No abstract available.
  • Delays in phases of care from identification to treatment of suspicious lung nodules.
    Rama N, Nordgren R, Husain AN, Juloori A, Bestvina CM, Thawani R, Garassino M, Murgu S, Wagh A, Hogarth DK, Barth C, Bryan D, Ferguson MK, Donington J, Madariaga ML. Rama N, et al. JTCVS Open. 2025 Jan 21;24:451-471. doi: 10.1016/j.xjon.2025.01.006. eCollection 2025 Apr. JTCVS Open. 2025. PMID: 40309697 Free PMC article.

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70 - PubMed
    1. Miller K.D., et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 2019;69 - PubMed
    1. Goldstraw P., et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer. J. Thorac. Oncol. 2016;11 - PubMed
    1. Darling G.E., et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J. Thorac. Cardiovasc. Surg. 2011;141:662–670. - PMC - PubMed
    1. Lathan C.S., Neville B.A., Earle C.C. Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J. Clin. Oncol. 2008;26 - PMC - PubMed

LinkOut - more resources